Jiangsu Hengrui Medicine
600276.SS
#478
Rank
HK$330.71 B
Marketcap
HK$51.84
Share price
2.06%
Change (1 day)
1.01%
Change (1 year)
Jiangsu Hengrui Medicine Company Limited is a Chinese pharmaceutical company engaged in the R&D, manufacturing and sales of healthcare products, including antineoplastic drugs, angiomyocardiac drugs, drugs for surgery, contrast agents and antibiotics

Market capitalization of Jiangsu Hengrui Medicine (600276.SS)

Market cap: HK$330.71 Billion

As of November 2024 Jiangsu Hengrui Medicine has a market cap of HK$330.71 Billion. This makes Jiangsu Hengrui Medicine the world's 478th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Jiangsu Hengrui Medicine from 2000 to 2024

End of year Market Cap

Year Marketcap Change
2024HK$330.71 B4.16%
2023HK$317.49 B15.31%
2022HK$275.34 B-30.63%
2021HK$396.89 B-43.81%
2020HK$706.34 B63.68%
2019HK$431.54 B95.12%
2018HK$221.16 B-4.85%
2017HK$232.42 B94.9%
2016HK$119.25 B3.77%
2015HK$114.92 B62.76%
2014HK$70.61 B6.67%
2013HK$66.19 B43.05%
2012HK$46.27 B13.57%
2011HK$40.74 B-22.44%
2010HK$52.53 B42%
2009HK$36.99 B63.74%
2008HK$22.59 B-13.48%
2007HK$26.11 B144.74%
2006HK$10.66 B195.11%
2005HK$3.61 B20.91%
2004HK$2.99 B49.02%
2003HK$2.00 B-16.84%
2002HK$2.41 B-28.92%
2001HK$3.39 B-10.07%
2000HK$3.77 B

End of Day market cap according to different sources

On Oct 31st, 2024 the market cap of Jiangsu Hengrui Medicine was reported to be:

HK$324.03 Billion
by Yahoo Finance info icon info icon
HK$324.03 Billion
by CompaniesMarketCap info icon info icon